CN Stock MarketDetailed Quotes

002864 Shaanxi Panlong Pharmaceutical

Watchlist
  • 26.95
  • +0.43+1.62%
Not Open Aug 8 15:00 CST
2.86BMarket Cap23.87P/E (TTM)

About Shaanxi Panlong Pharmaceutical Company

The company was founded in 1997 and is a modern high-tech enterprise integrating GAP cultivation of medicinal herbs, pharmaceutical production, R&D, sales and pharmaceutical logistics as its core industries. The company is a modern high-tech enterprise integrating standardized cultivation of medicinal herbs, pharmaceutical production, R&D, sales, and pharmaceutical logistics as its core industries. The leading product is Panlong Seven tablets. Corporate honors: AAA credit customers; model taxpayers; science and technology demonstration enterprises; AAA enterprises with quality service reputation in China; famous trademarks in Shaanxi Province; high-tech enterprises, etc. For many years in a row, it has been honored as a “Chinese Household Medication List Brand” product, a “Recommended Consumer Brand in the Traditional Chinese Medicine Market” product, and an “Ingenious Product”. The company won the 6th China Excellent IR “Best Shareholder Relationship Award” and won the honor of “2022 Excellent Investor Relations Management Unit”.

Company Profile

Short Name-A盘龙药业
Symbol-A002864
Company NameShaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Listing DateNov 16, 2017
Issue Price10.03
Shares Offered21.67M share(s)
FoundedSep 22, 1997
Listed ExchangeSZ Stock Exchange
Legal Representativexiaolin xie
General Managerqifei hu
Secretaryjie wu
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativexiaoni zhao
Legal CounselBeijing Ruiqiang Law Firm
Employees637
Phone029-83338888-8832
Office AddressNo. 2801, Baliu 2nd Road, Baqiao District, Xi'an, Shaanxi
Zip Code710025
Registered AddressZishui Panlong Ecological Industrial Park, Shangluo City, Shaanxi Province
Fax029-83592658
Email1970wujie@163.com
Business License610000100202319
BusinessGeneral projects: medical research and experimental development; sales of hygiene products and disposable medical products; sales of disinfectants (excluding hazardous chemicals); acquisition of Chinese herbal medicines; sale of Class II medical devices; Sales of Class I medical devices; Production of Class I medical devices; retail of cosmetics (except for projects subject to approval by law, independent business activities carried out on the basis of a business license in accordance with the law). License items: Pharmaceutical import and export; technology import and export; import and export agents; pharmaceutical production; disinfectant production (excluding hazardous chemicals); hygiene products and disposable medical products production; drug contract production; goods import and export; sterilizer production; pharmaceutical retail; road cargo transportation (excluding dangerous goods); class II medical device production; class III medical device management; cosmetics production; health products (non-food) production; health products (non-food) production; health products (non-food) sales; health food (non-food) sales; health food production; health food sales; food production (sales and pre-packaging) Food); production of formulated food for special medical purposes; sales of formula food for special medical purposes; Internet sales of food (sale of pre-packaged food); Internet sales of food (for items subject to approval according to law, business activities can only be carried out after approval by the relevant departments; specific business projects are subject to the approval results). (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • xiaolin xie
  • Chairman, Directors, Strategy Committee Members
  • 386.80K
  • jie wu
  • Directors, Board Secretary
  • 168.00K
  • dezhu zhang
  • Directors, Deputy General Manager, Strategy Committee Members
  • 153.90K
  • zhihong zhang
  • Directors, Nomination Committee Members
  • 126.00K
  • xiaofeng xie
  • Directors, Audit Committee Members, Remuneration and Assessment Committee Members
  • --
  • jilin huang
  • Directors, Deputy General Manager
  • 315.50K
  • haiyun ren
  • Independent Directors, Remuneration and Assessment Committee Members, Audit Committee Members
  • 80.00K
  • leipeng jiao
  • Independent Directors, Remuneration and Assessment Committee Members, Audit Committee Members, Nomination Committee Members
  • 80.00K
  • xiaofeng niu
  • Independent Directors, Strategy Committee Members, Nomination Committee Members
  • 80.00K
  • xiaoni zhao
  • Securities Affairs Representative
  • --
  • qingshui luo
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • 127.90K
  • wenfeng zhu
  • Shareholder Supervisors
  • 180.90K
  • hui ma
  • Shareholder Supervisors
  • 71.90K
  • qifei hu
  • General Manager
  • --
  • zhong meng
  • Deputy General Manager
  • 216.10K
  • fengming zhu
  • Chief Financial Officer
  • 128.40K
  • tailin xiong
  • Employee Supervisors
  • 113.80K
  • zhekun chen
  • Employee Supervisors
  • 371.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg